Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers
β Scribed by Yee-Lu Tham; L. Fernando Gomez; Syed Mohsin; M. Carolina Gutierrez; Heidi Weiss; Susan G. Hilsenbeck; Richard M. Elledge; Gary C. Chamness; C. Kent Osborne; D. Craig Allred; Jenny C. Chang
- Publisher
- Springer US
- Year
- 2005
- Tongue
- English
- Weight
- 181 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer The prognostic importance of angiogenesis in breast cancer has recently been discussed, and a significant relationship between vascular density and survival has been descri
## Abstract Twentyβone cancers in 20 patients with locally advanced breast cancer were studied. Incisional biopsy was performed without using electrocautery. Tissue was obtained for histology and estrogen (ER) and progesterone (PR) receptors. Patients received chemotherapy after biopsy. All respond
## Abstract ## Purpose To evaluate dynamic contrastβenhanced magnetic resonance imaging (DCEβMRI) as a tool for early prediction of response to neoadjuvant chemotherapy (NAC) and 5βyear survival in patients with locally advanced breast cancer. ## Materials and Methods DCEβMRI was performed in pa